Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens
Inhaled dry powder formulations of antiviral agents represent a novel and potentially transformative approach to managing respiratory viral infections. Traditional antiviral therapies in the form of tablets or capsules often face limitations in terms of therapeutic activity, systemic side effects, a...
Saved in:
| Main Authors: | Tushar Saha, Zia Uddin Masum, Anik Biswas, Moushumi Afroza Mou, Sohag Ahmed, Tamal Saha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/2/252 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced Manufacturing Methods for High-Dose Inhalable Powders
by: Haia A. Al-Assaf, et al.
Published: (2025-03-01) -
Dry Powder Inhalers for Delivery of Synthetic Biomolecules
by: Hossein Omidian, et al.
Published: (2025-01-01) -
Pulmonary delivery of insulin by dry powder inhaler formulations
by: Mohsen Imenshahidi, et al.
Published: (2025-07-01) -
EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2015-09-01) -
Circular RNAs in Viral Infection and Antiviral Treatment
by: Xiaocai Yin, et al.
Published: (2024-12-01)